You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb1980037 |
|---|---|
| Category | Small Molecules |
| Description | Moexiprilat, an active metabolite of the prodrug moexipril formed through side chain ester hydrolysis in vivo, functions as an angiotensin-converting enzyme (ACE; IC50 = 2.1 nM) inhibitor. At a concentration of 10 nM, it inhibits the proliferation of primary neonatal rat cardiac fibroblasts stimulated by estrone or angiotensin II. Furthermore, when given at a daily dosage of 50 mg/kg, moexiprilat reduces mean arterial blood pressure and elevates levels of atrial natriuretic peptide, an indicator of hypertension, in ovariectomized mice. |
| Target | Others |
| MW | 470.51 |
| CAS Number | 103775-14-0 |
| Formula | C25H30N2O7 |
| SMILES | C[C@H](N[C@H](C(O)=O)CCC1=CC=CC=C1)C(N2CC3=CC(OC)=C(OC)C=C3C[C@H]2C(O)=O)=O |
| Storage | -20°C |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)